A specific and sensitive radioimmunoassay for rat C-peptide
Tóm tắt
A sensitive and specific radioimmunoassay for rat serum C-peptide (RCP) has been developed and validated using a guinea pig anti-rat C-peptide antibody to synthetic rat C-peptide. Negligible crossreactivity (<0.01%) to human proinsulin was observed, whereas human insulin, human pancreatic polypeptide (hPP), porcine insulin, porcine C-peptide, bovine insulin, rat insulin, porcine-PP, and glucagon, respectively, did not produce measurable displacement of RCP tracer. Human C-peptide even in a supraphysiological concentration range crossreacted poorly (<0.1%). The sensitivity limit of the assay calculated at ±3 standard deviations was 24.2pM (0.07 ng/mL). RCP standard concentrations ranged from 25–1600pM. The intraassay-and between assay-coefficient of variations (CV) were 3.5–6.1% and 4.1–9.5%, respectively. The mean percentage recovery of RCP added to rat serum samples was 100.8±2%. Serum volume dilution from 25 to 100 μL did not significantly alter the expected RCP level. Migration of rat serum C-peptide and that of synthetic RCP were identical in a Sephadex G-50 chromatographic analysis. The mean fasting and postprandial plasma RCP levels in normal rats were 102±15pM and 485±75pM, respectively. RCP levels following intravenous glucose tolerance test in diabetic and nondiabetic rats were consistent with expected patterns. In conclusion, we have developed and validated a rat C-peptide assay that is sensitive, simple, and specific for RCP in serum. The assay provides a reliable tool for studies of diabetes using rodent animal models.
Tài liệu tham khảo
Ashby P, Frier BM. Circulating C-peptide: Measurement and clinical application.Am Clin Biochem 1981; 18: 125–130.
Bonser AM, Garcia-Webb P. C-peptide measurement: Methods and clinical utility, inCritical Reviews in Clinical Lab Sc 1984; 19(4): 297–352.
Dryburgh JR, Hampton SM, Marks V. Endocrine pancreatic control of the release of gastric inhibitory polypeptide.Diabetologia 1980; 19: 397–401.
Flatt PR, Bailey CJ, Hampton SM, Swanston-Flatt SK, Marks V. Immunoreactive C-peptide in spontaneous syndromes of obesity and diabetes in mice.Horm Metabol Res 1987; 19: 1–5.
Greenwood FC, Hunter WM, Glover JS. The preparation of 131-I-labeled human growth hormone of high specific radioactivity.Biochem J 1963; 89: 114–123.
Heding LG, Larsen UD, Markussen J, Jorgensen KH, Hallund O. Radioimmunoassays for human, pork and ox C-peptides and related substances.Horm Metab Res Suppl 5: 1974; 5: 40–45.
Katz AL, Rubenstein AH. Metabolism of proinsulin insulin and C-peptide in the rat.J Clin Invest 1973; 52: 1113–1121.
Kuhl C, Faber OK, Hornnes P, Jensen SL. C-peptide metabolism and the liver.Diabetes 1978; 27 (Suppl 5): 197–200.
Linde S, Nielsen JH, Hansen B, and Welinder BS. Reversed-phase high-performance liquid chromatographic analyses of insulin biosynthesis in isolated rat and mouse islets.J Chromatog 1989; 462: 243–249.
Rubenstein AH, Block MB, Starr J, Melani F, Steiner DF. Proinsulin and C-peptide in blood.Diabetes 1972; 21(Suppl 2): 661–672.
Sandler R, Horwitz DL, Rubenstein AH, Kuzuyah H. Hypoglycemia and endogenous hyperinsulinism complicating diabetes mellitus: Application of the C-peptide assay to diagnosis and therapy.Am J Med 1975; 59: 730–736.
Steiner DF. On the role of the proinsulin C-peptide.Diabetes 1978; 27(Suppl. 1): 145–148.
Steiner DF, Hallund O, Rubenstein AH, Cho S, Bayliss C. Isolation and properties of proinsulin intermediate forms and other minor components from crystalline bovine insulin.Diabetes 1968; 17: 725–736.
Wojcikowski C, Maier V, Dominiak K, Fussganger R, Pfeiffer EF. Effects of synthetic rat C-peptide in normal and diabetic rats.Diabetologia 1983; 25: 288–290.
Yanaihava C, Ozaki J, Nishida T, Iizuk Y, Sato H, Yanaihava H, Kaneko T. Immunological studies on synthetic rat and guinea pig C-peptides, inProinsulin and C-Peptide, Baba S, Kaneko T, Yanaihava V, eds. Excerpta Medica 1979; Amsterdam pp. 87–93.
Yanaihava N, Yanaihava C, Sakagami M, Sakura N, Hashimoto T, Nishida T. Syntheses of C-peptides and human proinsulin.Diabetes 1978; 27(Suppl 1): 149–160.
Zettner A. Principles of competitive binding assays (saturation analyses). II. Sequential saturation.Clin Chem 1974; 20: 5–9.